|Bid||205.00 x 900|
|Ask||260.00 x 800|
|Day's Range||225.83 - 231.85|
|52 Week Range||181.51 - 249.95|
|Beta (3Y Monthly)||1.33|
|PE Ratio (TTM)||38.36|
|Earnings Date||Oct 24, 2018|
|Forward Dividend & Yield||0.68 (0.29%)|
|1y Target Est||262.60|
Wall Street analysts expect Thermo Fisher Scientific’s (TMO) third-quarter revenues to increase ~11.5% to $5.7 billion—compared to its revenues of $5.1 million during the third quarter of 2017. The adjusted EPS is estimated to be $2.55 for the third quarter—compared to the adjusted EPS of $2.31 in the third quarter of 2017.
As we discussed in the previous part, Wall Street analysts expect Thermo Fisher Scientific (TMO) to report 11.5% revenue growth to $5.70 billion during the third quarter. Thermo Fisher provides products and services through its brands including Thermo Scientific, Fisher Scientific, Invitrogen, Unity Lab Services, and Applied Biosystems.
Thermo Fisher Scientific (TMO), a leading life sciences company, is scheduled to release its third-quarter earnings on October 24. Wall Street analysts expect the adjusted EPS to be $2.55 on revenues of $5.7 billion during the third quarter.
The latest enhancements in Pacific Biosciences??? (PACB) Sequel System represent strong improvement in terms of read length, throughput and accuracy in DNA sequencing.
Quest Diagnostics' (DGX) growing partnerships with health care leaders and strategic acquisitions are expected to boost top and bottom-line growth in Q3.
In September 2018, Medtronic (MDT) announced that the company would acquire all outstanding shares of Mazor Robotics (MZOR) for $58.50 per American depositary share (or $29.25 per ordinary share), which amounts to a total of $1.64 billion (or $1.34 billion). Both companies’ boards of directors unanimously approved the transaction.
In the first quarter of fiscal 2019, Medtronic generated net revenues of $7.4 billion, a ~0.1% year-over-year (or YoY) decline. Wall Street analysts estimate that Medtronic will generate revenues of $7.3 billion in the second quarter of fiscal 2019.
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How Is Medtronic Positioned in October? On October 12, Medtronic stock closed at $94.69, which is a ~1.7% rise from its prior-day close of $93.11 on October 11 and a ~24% rise from its 52-week low of $76.41. Medtronic hit its 52-week high of $100.15 on September 26, 2018.
Edwards Lifesciences (EW) will release its third-quarter earnings results on October 23. The company is expected to register adjusted EPS of ~$1.02, a ~21% YoY (year-over-year) rise.
Edwards Lifesciences (EW) is scheduled to announce its third-quarter earnings results after the market closes on October 23. The company is a leading player in the artificial heart valve market.
Abbott Laboratories (ABT) plans to release its earnings results for its third quarter of 2018 on October 17 before the market opens. Wall Street expects its sales to be $7.65 billion, up 12% YoY (year-over-year).
Rising incidence of infectious diseases and increasing acceptance of companion diagnostics are driving the molecular diagnostics market.
Abbott Laboratories (ABT) is slated to announce its Q3 earnings results on October 17. Let’s look at Wall Street analysts’ recommendations for ABT stock ahead of its earnings release.
The Dow Jones Industrial Average dropped by 832 points on Wednesday, its third-worst one-day fall ever.
During the investor update at the TCT (Transcatheter Cardiovascular Therapeutics) meeting on September 24, Boston Scientific increased its long-term outlook. For 2019 and 2020, it now expects operational sales growth of 7%–10%, which compares to the previous guidance of 6%–9%. It expects growth to be driven by both organic and inorganic growth.
George Hatsopoulos preferred to hole up in his home study, fogged with pipe smoke, and elaborate his theories on thermodynamics or economic policy. A Greek immigrant who settled in the Boston area, he founded a Fortune 500 company, Thermo Electron Corp., and ran it for 43 years.
Abbott Laboratories (ABT) offers market-leading products and solutions across its Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals operating segments.
CEO of Thermo Fisher Scientific Inc (NYSE:TMO) Marc N Casper sold 125,520 shares of TMO on 10/01/2018 at an average price of $247.5 a share.